The glutathione system: a new drug target in neuroimmune disorders.
about
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's DiseaseMechanisms underlying neurocognitive dysfunctions in recurrent major depressionStructure and mechanism of action of tau aggregation inhibitors.Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses.The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disordersDimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro.Inflammation in Depression and the Potential for Anti-Inflammatory TreatmentStore-operated Ca2+ entry controls ameloblast cell function and enamel development.Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β-amyloid toxicity, and astrocyte function.The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.The Putative Role of Environmental Mercury in the Pathogenesis and Pathophysiology of Autism Spectrum Disorders and Subtypes.Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium.Carnosic Acid Affords Mitochondrial Protection in Chlorpyrifos-Treated Sh-Sy5y Cells.Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome.Nrf2-a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke.Resveratrol and Brain Mitochondria: a Review.CerefolinNAC Therapy of Hyperhomocysteinemia Delays Cortical and White Matter Atrophy in Alzheimer's Disease and Cerebrovascular Disease.Monomethyl fumarate inhibits pain behaviors and amygdala activity in a rat arthritis model.Naringenin Attenuates H2O2-Induced Mitochondrial Dysfunction by an Nrf2-Dependent Mechanism in SH-SY5Y Cells.Pinocembrin Suppresses H2O2-Induced Mitochondrial Dysfunction by a Mechanism Dependent on the Nrf2/HO-1 Axis in SH-SY5Y Cells.Conjugated linoleic acid prevents age-dependent neurodegeneration in a mouse model of neuropsychiatric lupus via the activation of an adaptive response.Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia.Carnosic Acid as a Promising Agent in Protecting Mitochondria of Brain Cells.Metallo-pathways to Alzheimer's disease: lessons from genetic disorders of copper trafficking.Modulation of Corpus Striatal Neurochemistry by Astrocytes and Vasoactive Intestinal Peptide (VIP) in Parkinsonian Rats.Stimulation of cell proliferation by glutathione monoethyl ester in aged bone marrow stromal cells is associated with the assistance of TERT gene expression and telomerase activity.Sulforaphane Promotes Mitochondrial Protection in SH-SY5Y Cells Exposed to Hydrogen Peroxide by an Nrf2-Dependent Mechanism.Pinocembrin Provides Mitochondrial Protection by the Activation of the Erk1/2-Nrf2 Signaling Pathway in SH-SY5Y Neuroblastoma Cells Exposed to Paraquat.Genomic Profile of Fatigued Men Receiving Localized Radiation Therapy.Fructus and Its Active Ingredients as Promising Resources for the Treatment of Neurological DiseasesStructure-Based Discovery and Synthesis of Potential Transketolase Inhibitors
P2860
Q26739412-3983A548-AC73-477F-9FDB-2B9888DC4F93Q26863677-85D40530-15D9-4DA3-9BDC-7593518F3465Q34902096-C0CEB1A7-DBB0-441F-8424-813646E94FFFQ35059951-043D9950-1850-48FE-80AF-C4265E06B1C4Q35246024-3B6E733E-684D-41BF-9D3F-4D1A9F319726Q35582048-CBB50DF1-9522-4242-BB7D-BF2B95C50DF8Q37310528-768E5CAD-1374-44A5-881D-C2C4DE61EB94Q37711776-ECF4DDCD-D36C-4662-966B-4DB9FACB9BA8Q38400509-FE71588D-F4A5-41D0-B719-CE7AC4660994Q38574561-147C6054-7AF6-47A4-914C-34D345CA789AQ38653427-143F90F7-55F6-4118-B5BA-2C6D37D63B3AQ38715233-361893C0-2272-4177-9006-837B4233BCF3Q38777868-62E3AAEC-FB9A-4219-B1AC-8C638894B6C8Q38875536-E7965606-5DC4-40BB-BA18-B4976A1DC237Q38970553-B08A9F78-6D7E-47FF-897C-86CB928E717EQ39173672-56E56F19-C1B1-494C-9FDE-0F31535D9912Q43731866-945BE17A-D930-4212-A712-D7AA577C5C6AQ46317549-99D17A68-0DF0-480C-9CE5-2896B39EF73CQ46324359-0B988275-ECF0-4C98-8324-CD1C8899E6CAQ46433045-E734FCB0-472D-4169-AB50-600D2325BB7AQ47426320-09ACE809-53FE-4957-AD63-4F32D547F4FEQ47824619-93A1C114-AD33-4B09-AF23-FDCFF12A7654Q47863411-B68CF42C-D6A0-4D36-A874-AD905FBDF8EDQ47985612-B0744D2B-0AF1-417B-959B-1762C2B0891EQ48793040-B5B7808E-BEC3-44A3-AA11-A94D72CE64B8Q50201467-C25A295B-A4F3-4C9D-99B3-AE80FCBCE7FAQ50878532-58B7623D-2125-4ECC-AF61-CC2169CF37F8Q51438822-77231911-5B5C-46D2-94A4-F3D928BBBD68Q52899597-CA8F4B37-70D5-406F-9E3A-B1FD9DEB0B68Q57176951-ECC9F4AB-4082-48B5-98B0-FB06BB963649Q58696328-51D27EEA-2744-47C9-94FF-03CCB01535B6
P2860
The glutathione system: a new drug target in neuroimmune disorders.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The glutathione system: a new drug target in neuroimmune disorders.
@en
type
label
The glutathione system: a new drug target in neuroimmune disorders.
@en
prefLabel
The glutathione system: a new drug target in neuroimmune disorders.
@en
P2093
P2860
P1476
The glutathione system: a new drug target in neuroimmune disorders.
@en
P2093
Gerwyn Morris
Marta Martin-Subero
Michael Maes
Olivia Dean
Piotr Galecki
P2860
P2888
P304
P356
10.1007/S12035-014-8705-X
P577
2014-04-22T00:00:00Z
P5875
P6179
1043110700